1. "GSK Faculty"
Formats
  1. Journal Article (13834)
  2. Meeting Abstract (7076)
  3. Review (514)
  4. Book Section (342)
  5. Editorial (307)
  6. Conference Paper (162)
  7. Research Letter (96)
  8. Miscellaneous (45)
  9. Correspondence (38)
  10. Guidelines (32)
  11. Book Whole (22)
Groups
  1. GSK Faculty (22468)
  2. Sloan Kettering Institute Faculty (11482)
  3. Department of Medicine (10529)
  4. Tow Center for Developmental Oncology (TCDO) (6948)
  5. Sloan Kettering Institute Postdocs (6210)
  6. Solid Tumor Oncology Division (5880)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Steven Larson (957)
  3. Jedd Wolchok (905)
  4. Cristina Antonescu (895)
  5. Kenneth Offit (788)
  6. David Solit (779)

More People

Years
  1. 2025 (296)
  2. 2024 (868)
  3. 2023 (1016)
  4. 2022 (1152)
  5. 2021 (1088)
  6. 2020 (1257)

More Years

Publications
  1. Blood (1470)
  2. Journal of Clinical Oncology (1279)
  3. Cancer Research (1104)
  4. Clinical Cancer Research (527)
  5. Modern Pathology (494)
  6. Journal of Nuclear Medicine (474)

More Publications

Publishers
  1. Nature Publishing Group (2594)
  2. American Association for Cancer Research (2194)
  3. Elsevier Inc. (1937)
  4. American Society of Hematology (1553)
  5. Cell Press (1421)
  6. American Society of Clinical Oncology (1379)

More Publishers

Results (22468)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • ESR1 and endocrine therapy resistance: More than just mutations
    Journal Article

    Piscuoglio, S.; Ng, C. K. Y.; Weigelt, B.; Chandarlapaty, S.; Reis-Filho, J. S.
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Noninvasive molecular profiling by circulating cell-free DNA in pediatric solid tumors
    Meeting Abstract

    Kothari, P.; Slotkin, E.; Yang, J.; Stewart, C.; Gedvilaite, E.; Berger, M.; Ladanyi, M.; Shukla, N.; Modak, S.; Tsui, D.
    Pediatric Blood and Cancer (2018)

    Fulltext@MSK | Save
  • Determination of MLH1 and MGMT promoter methylation status using the Illumina high-throughput methylationEPIC (850k) platform
    Meeting Abstract

    Benhamida, J.; Ladanyi, M.; Wang, J.
    Modern Pathology (2018)

    Fulltext@MSK | Save
  • Specificity of BCOR immunohistochemistry in pediatric renal neoplasia
    Meeting Abstract

    Argani, P.; Pawel, B.; Szabo, S.; Reyes-Múgica, M.; Antonescu, C. R.
    Modern Pathology (2018)

    Fulltext@MSK | Save
  • Next-generation sequencing and clinicopathologic analysis of 101 pulmonary invasive mucinous adenocarcinomas focusing on comparison among molecular subtypes
    Meeting Abstract

    Chang, J.; Arcila, M.; Montecalvo, J.; Desmeules, P.; Benayed, R.; Teed, S.; Sabari, J.; Borsu, L.; Travis, W.; Ladanyi, M.; more...
    Modern Pathology (2018)

    Fulltext@MSK | Save
  • Prominent expression of the negative immune checkpoint regulator VISTA in malignant pleural mesothelioma (MPM)
    Meeting Abstract

    Muller, S.; Zauderer, M.; Desmeules, P.; Jungbluth, A.; Fayad, M.; Frosina, D.; Ni, A.; Ladanyi, M.; Sauter, J. L.
    Modern Pathology (2018)

    Fulltext@MSK | Save
  • Comparison of MTAP immunohistochemistry (IHC) with p16/CDKN2A deletions/loss and utility of MTAP and BAP1 IHC in the diagnosis of malignant pleural mesothelioma (MPM)
    Meeting Abstract

    Shahi, M.; Eguchi, T.; Zauderer, M.; Travis, W.; Jungbluth, A.; Frosina, D.; Fayad, M.; Asher, M.; Adusumilli, P. S.; Ladanyi, M.; more...
    Modern Pathology (2018)

    Fulltext@MSK | Save
  • Thoracic hyalinizing clear cell carcinoma: A series of 3 cases
    Meeting Abstract

    Montecalvo, J.; Wang, L. C.; Chen, C. J.; Rekhtman, N.; Katabi, N.; Ghossein, R.; Antonescu, C. R.; Travis, W.
    Modern Pathology (2018)

    Fulltext@MSK | Save
  • SMARCA4 (BRG1) deficiency in lung carcinomas correlates with poor differentiation and aggressive clinical behavior
    Meeting Abstract

    Montecalvo, J.; Alex, D.; Ptashkin, R.; Ni, A.; Sauter, J. L.; Chang, J.; Beras, A.; Namakydoust, A.; Rudin, C.; Ladanyi, M.; more...
    Modern Pathology (2018)

    Fulltext@MSK | Save
  • Pulmonary BRG1 (SMARCA4)-deficient undifferentiated neoplasms represent an exceptionally aggressive type of sarcomatoid carcinoma: Clinicopathologic and genomic evidence supports a link to non-small cell carcinoma
    Meeting Abstract

    Montecalvo, J.; Alex, D.; Ptashkin, R.; Ni, A.; Sauter, J. L.; Chang, J.; Jungbluth, A.; Beras, A.; Namakydoust, A.; Rudin, C.; more...
    Modern Pathology (2018)

    Fulltext@MSK | Save